| December 28, 2012 | News for the transfusion medicine and cellular therapy community |
 |  |
- N.Y. considers rules to prevent sepsis deaths
Following the death of a 12-year-old boy, New York state has proposed regulations requiring that hospitals aggressively look for sepsis in patients to enable earlier treatment. New York could become the first state to adopt such rules. Early symptoms of sepsis can be difficult to distinguish from those of other, less serious maladies, but "[f]irst and foremost, they need to suspect sepsis," the most common cause of death in ICUs, said Dr. Mitchell M. Levy. Treatment includes antibiotics and fluids. The New York Times (tiered subscription model)
(12/20)     
|
|
NEW Complement Coated C3 Control Cells!
Hemo bioscience has received FDA clearance for its complement coated control cells. Hemo bioscience C3 Control Cells can be used as a control to confirm the efficacy of the AHG reagent used during Direct and Indirect Anti-Globulin tests. For details regarding pricing, manufacturing schedule, and distribution channels email us or call 866-332-2835. |
- Cholesterol drug may help children with malaria
An international team of researchers found that adding the cholesterol drug lovastatin to malaria treatment chloroquine could prevent the late cognitive problems associated with cerebral malaria, according to a mouse model study published in the journal PLoS Pathogens. Lead researcher Dr. Guy Zimmerman of the University of Utah says lovastatin should be added to treatments for malaria. Voice of America
(12/27)
|
|
Want More CME/CE Credit from AABB?
Now it's even easier to accomplish your training needs and earn CME/CE credits. Convenient and accessible anytime, the AABB Live Learning Center offers quick access to essential Annual Meeting and audioconference content. Most products offer CME/CE tracking and attendance certification. Click here to get started! |
| Emerging Trends |  |  |
|
| Industry News & Practice | | |
|
- Stem cell startup gets support in Wis.
The Wisconsin Economic Development Corp. has approved tax credits for Regenerative Medical Solutions and several other startups under the Qualified New Business Venture program. Regenerative Medical Solutions develops pancreatic stem cells for use in research on treatments for diabetes. Wisconsin State Journal (Madison)
(12/27)
| Government & Regulatory | | |
|
| Association News | | |
|
-
NBF accepting donations to support research grants
The National Blood Foundation, or NBF, is accepting donations to support research grants and other initiatives that benefit patients and donors. The research grants provide funding for one- or two-year projects in transfusion medicine and cellular therapies. Since 1985, the NBF has awarded more than $7.5 million in grants to 177 scientific investigators to advance the field. All donations are tax-deductible to the fullest extent allowed by law.
| SmartQuote | | |
|
 | If all misfortunes were laid in one common heap whence everyone must take an equal portion, most people would be contented to take their own and depart."
--Socrates,
Greek philosopher
|
| |
| |
|
Read more at SmartBrief.com |
|
A powerful website for SmartBrief readers including:
|
|
|
|
| |
| |
| | Recent AABB SmartBrief Issues:
- Thursday, December 27, 2012
- Wednesday, December 26, 2012
- Monday, December 24, 2012
- Friday, December 21, 2012
- Thursday, December 20, 2012
| | | Lead Editor: Tom Parks
Managing Editor: Cristian Becker
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | |
| |
|
| © 1999-2013 SmartBrief, Inc.® Legal Information |
|
